Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?

Name: Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?
SKU: 5153
Availability: InStock

$0.00

Pharmacy Practice

The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer:

What Should Patients Be Told?

By Judith A. Smith, PharmD, BCOP

Want a discount? Become a member by purchasing Psychopharmacology Bulletin Subscription - Individual!

Categories: Oncology Spectrums, Oncology Spectrums Volume 2 No. 6 Tags: development-of-ovarian-cancer, infertility, judith-a-smith, pharmacy-practice

Description

Description

Pharmacy Practice

The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer:

What Should Patients Be Told?

By Judith A. Smith, PharmD, BCOP

0601-Pharm-P-Smith-5.23.mm_

Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?

Description

Assessing the Older Cancer Patient

Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications

Use of Colony-Stimulating Factors in the Elderly Cancer Patient

Oncology Spectrums: Volume 2 No. 7

Pharmacy Practice: The Controversial Association of the Treatment of Infertility With Fertility Agents and Development of Ovarian Cancer: What Should Patients Be Told?

Description

Related products

Assessing the Older Cancer Patient

Hyperprolactinemia, Clinical Considerations, and Infertility in Women on Antipsychotic Medications

Use of Colony-Stimulating Factors in the Elderly Cancer Patient

Oncology Spectrums: Volume 2 No. 7